San Mateo County Logo
File #: 16-723    Version: 1 Name:
Type: Resolution Status: Passed
File created: 10/12/2017 Departments: HEALTH
On agenda: 11/7/2017 Final action: 11/7/2017
Title: Adopt a resolution authorizing an agreement with the California Department of Public Health, Safe and Active Communities Branch, to receive Narcan nasal spray, a product of Naloxone, for the term of January 1, 2017 through June 30, 2019, for an estimated revenue total of $26,040.
Attachments: 1. BOS Reso.pdf, 2. 2017-19 Grant.pdf
Date Ver.Action ByActionResultAction DetailsMeeting DetailsVideo
No records to display.
Special Notice / Hearing: None__
Vote Required: Majority

To: Honorable Board of Supervisors
From: Louise Rogers, Chief, Health System
David Young, Director, Behavioral Health and Recovery Services
Subject: Agreement with California Department of Public Health, Safe and Active Communities Branch for Naloxone Distribution in San Mateo County

RECOMMENDATION:
title
Adopt a resolution authorizing an agreement with the California Department of Public Health, Safe and Active Communities Branch, to receive Narcan nasal spray, a product of Naloxone, for the term of January 1, 2017 through June 30, 2019, for an estimated revenue total of $26,040.

body
BACKGROUND:
Senate Bill 833 (Chapter 30, Statutes of 2016) introduced a new Naloxone Grant Program within the California Department of Public Health (CDPH) that aims to reduce the number of fatal overdoses in California from opioid drugs, including prescription opioids and heroin, by increasing access to the life-saving drug Narcan nasal spray, a naloxone product. San Mateo County is 1 of 61 California health departments that were granted one of these non-competitive grants. BHRS is receiving an estimated 696 doses of Narcan nasal spray that will save the lives of approximately 348 San Mateo County residents that experience opioid overdose.

DISCUSSION:
Narcan is a medication that works almost immediately to reverse opiate overdose. Narcan is currently a prescription drug, but is not a controlled substance. It has few known side effects, no potential for abuse, and can be rapidly administered through intramuscular injection or nasal spray.

Through this agreement, the BHRS Medical Director will work with community-based organizations (CBOs) to provide direct services to opioid users and distribute/administer Narcan nasal spray. CBO staff are trained on naloxone storage and administration, as well as overdose prevention techniques. Staff know how to recognize an opioid overdose; dispense n...

Click here for full text